News Archive
New research found clinicians who care for patients with osteoarthritis (OA) are likely not following standard care guidelines that are based on current medical evidence. Researchers noted physicians were prescribing medications for pain and inflammation, or opting for surgical interventions rather than recommending weight loss plans or exercise programs to OA patients.
Arena Pharmaceuticals announced today results from the dosing phase of its Phase 1b clinical trial of APD356, an orally administered small molecule designed to regulate satiety (and perhaps metabolism) for the treatment of obesity.
Beginning in March, the Virginia Department of Health (VDH) will host eight planning meetings to get input from residents on how to prevent and control obesity in the state.
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced that a Phase 2a proof-of-concept study of dupilumab, an investigational therapy that blocks IL-4 and IL-13 signaling, met all primary and secondary endpoints in patients with moderate-to-severe chronic sinusitis with nasal polyps (CSwNP) who did not respond to intranasal corticosteroids.
Disability Rights Network of Pennsylvania filed a class action lawsuit in U.S. District Court today against the Pennsylvania Department of Public Welfare alleging multiple violations of federal law in how DPW provides services to deaf persons with intellectual disabilities.
› Verified 2 days ago